VEGFA and renal cell carcinoma: Immune checkpoint inhibitor (ICI) combination therapies and ICI plus vascular endothelial growth factor (VEGF)–targeted therapy are recommended as standard primary treatments for advanced renal cell carcinoma (RCC) by the National Comprehensive Cancer Network guidelines (1–5).